爵士制药 JAZZ
$234.76 +$7.44 (+3.27%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $237.00 +0.95%
开盘$226.66
昨收$227.32
当日区间$225.50 – $237.76
成交量887.6K
市值$15.07B
市盈率（TTM）69.5
股息率–
财报
财报日平均波动±5.4%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+13.2%
最差反应-9.1%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 3 Aug 2026 | After Market | ±6.5% | +3.99% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±6.2% | +7.68% | 超出定价预期 |
| 2025/Q4 | 24 Feb 2026 | After Market | ±7.8% | +13.23% | 超出定价预期 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±7.8% | -2.31% | 符合区间 |
| 2025/Q2 | 5 Aug 2025 | After Market | ±10.6% | -6.42% | 符合区间 |
| 2025/Q1 | 6 May 2025 | After Market | ±11.5% | -8.75% | 符合区间 |
| 2024/Q4 | 25 Feb 2025 | After Market | ±8.5% | +3.22% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±7.8% | +6.75% | 符合区间 |
| 2024/Q2 | 31 Jul 2024 | After Market | ±9.9% | +3.75% | 符合区间 |
| 2024/Q1 | 1 May 2024 | After Market | ±8.3% | -0.92% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±8.7% | -8.33% | 符合区间 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±7.8% | -9.14% | 超出定价预期 |
| 2023/Q2 | 9 Aug 2023 | After Market | ±7.4% | +1.64% | 符合区间 |
| 2023/Q1 | 10 May 2023 | After Market | ±6.2% | +0.41% | 符合区间 |
| 2022/Q4 | 1 Mar 2023 | After Market | ±7.8% | +2.73% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±6.9% | +7.07% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.21B+15.5% YoY
营业利润$325.20M+48.5% YoY
净利润$192.80M+126.8% YoY
摊薄每股收益$2.78+123.7% YoY
自由现金流$243.40M+220.7% YoY
经营现金流$415.70M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率88.4%
营业利润率22.1%
净利率20.4%
净资产收益率22.1%
资产收益率8.5%
投入资本回报率11.4%
流动比率1.78
负债/资产比率56.7%
现金及投资$2.20B
总负债$4.40B
净现金（净负债）-$2.20B
自由现金流/营收28.5%
暂无评论——快来第一个聊聊 JAZZ。
登录后参与讨论。